FUJIFILM Wako Diagnostics U.S.A. Corporation is a leading provider of in vitro diagnostic solutions, specializing in biomarker tests for chronic liver disease, particularly hepatocellular carcinoma (HCC). Their AFP-L3 and DCP tests aid in the early identification of patients at risk of developing HCC, complementing other laboratory findings, imaging studies, and clinical assessments.
In addition to their biomarker tests, FUJIFILM Wako Diagnostics offers a range of in vitro diagnostic reagents and systems, providing comprehensive solutions for clinical and research needs. With a commitment to innovation and quality, they are at the forefront of generating advanced diagnostic tools to improve patient outcomes in the field of liver disease and beyond.
Generated from the website